BTI - British American Tobacco p.l.c.

NYSE - NYSE Delayed Price. Currency in USD
62.43
-0.42 (-0.67%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close62.85
Open62.22
Bid61.84 x 100
Ask61.85 x 100
Day's Range62.16 - 63.04
52 Week Range60.15 - 73.41
Volume1,574,591
Avg. Volume1,901,837
Market Cap132.596B
Beta0.85
PE Ratio (TTM)19.80
EPS (TTM)3.15
Earnings DateN/A
Forward Dividend & Yield1.17 (1.88%)
Ex-Dividend Date2017-12-28
1y Target Est80.00
Trade prices are not sourced from all markets
  • Your Simple Guide to Tobacco Stocks
    Motley Fool17 hours ago

    Your Simple Guide to Tobacco Stocks

    Find out how to invest in this key consumer goods area.

  • MarketWatch8 days ago

    Manager of $8.6 billion international fund makes bets that take guts

    Harry W. Hartford of Causeway Capital Management looks for special opportunities in downtrodden stocks. By Phil van Doorn.

  • Why Philip Morris’s Stock Price Rose after 4Q17 Earnings
    Market Realist8 days ago

    Why Philip Morris’s Stock Price Rose after 4Q17 Earnings

    Philip Morris’s 4Q17 Earnings: Important Takeaways4Q17 performance

  • Reuters9 days ago

    Tobacco firms in France cheated nicotine tests: anti-smoking body

    Four tobacco companies operating in France manipulated tests to conceal the real level of nicotine and tar contained in cigarettes, endangering the lives of smokers, a French anti-smoking organisation alleged in a legal complaint. The allegations by the National Committee Against Smoking (CNCT) target the French branches of Philip Morris, British American Tobacco, Japan Tobacco and Imperial Brands Plc.

  • How Analysts View Altria after Its 4Q17 Earnings
    Market Realist11 days ago

    How Analysts View Altria after Its 4Q17 Earnings

    Altria Tops 4Q17 Earnings Estimates but Misses Revenues

  • Why Altria’s 4Q17 Earnings Failed to Impress Investors
    Market Realist12 days ago

    Why Altria’s 4Q17 Earnings Failed to Impress Investors

    Altria Tops 4Q17 Earnings Estimates but Misses Revenues4Q17 performance

  • Does British American Tobacco plc’s (LON:BATS) Debt Level Pose A Problem?
    Simply Wall St.13 days ago

    Does British American Tobacco plc’s (LON:BATS) Debt Level Pose A Problem?

    The size of British American Tobacco plc (LSE:BATS), a £108.88B large-cap, often attracts investors seeking a reliable investment in the stock market. One reason being its ‘too big to fail’Read More...

  • InvestorPlace16 days ago

    Will Altria Group Inc Shareholders See The Company Go Up In Smoke?

    Altria Group Inc (NYSE:MO) could have had a better quarter, but they also could have had a worse The cigarette maker is successfully “doing more with less,” between the smoking-cessation headwind and impending exit of CEO Marty Barrington. Altria remains a leader in its respective market, but it’s a market with a dim future. For the quarter ending in December, Altria Group turned $6.1 billion worth of revenue and net-revenues (net of excise taxes) of $4.7 billion into an operating profit of 91 cents per share.

  • Philip Morris: Wall Street Recommendations ahead of 4Q17 Earnings
    Market Realist16 days ago

    Philip Morris: Wall Street Recommendations ahead of 4Q17 Earnings

    As of January 30, Philip Morris International (PM) was trading at $107.94. Analysts were expecting the company’s stock price to reach $122.73 in the next 12 months, which represents a return potential of 13.7%. Before the announcement of the company’s 3Q17 earnings, analysts had forecasted a 12-month target price of $122.41.

  • American City Business Journals18 days ago

    What a recent FDA recommendation could mean for Reynolds American

    An advisory committee to the U.S. Food and Drug Administration recently voted to reject a claim from a company that its tobacco-heating product be marketed as "reduced risk" during a review process Reynolds American Inc. also started in December 2017, but no applications for the marketing of "reduced risk" products have yet to be accepted in the U.S. The Tobacco Products Scientific Advisory Committee voted 5-4 to reject a claim by Phillip Morris that “switching completely to IQOS presents less risk of harm than continuing to smoke cigarettes,” thus recommending to the FDA that it issue the same ruling.

  • Did Trump's Tax Reform Just Help Level the E-Cig Playing Field?
    Motley Fool18 days ago

    Did Trump's Tax Reform Just Help Level the E-Cig Playing Field?

    British American Tobacco will get a cash infusion to push forward its next-gen tobacco products.

  • New E-Cig Study Poses Risk for Philip Morris International
    Motley Fool20 days ago

    New E-Cig Study Poses Risk for Philip Morris International

    While there was good news in the report, the negative points may weigh most heavily.

  • Philip Morris Knockback Leaves Cigarette Alternatives in Limbo
    Bloomberg23 days ago

    Philip Morris Knockback Leaves Cigarette Alternatives in Limbo

    Big Tobacco is spending billions of dollars to develop products that could move the industry beyond cigarettes. The problem is that health experts and regulators aren’t buying it.

  • Why Did Altria and Philip Morris Stock Decline on January 25?
    Market Realist23 days ago

    Why Did Altria and Philip Morris Stock Decline on January 25?

    On January 25, 2018, the stock prices of Altria Group (MO) and Philip Morris (PM) fell 2.3% and 2.8%, respectively. On January 25, the FDA’s advisory panel rejected two of Philip Morris’s claims while approving one claim.

  • What Analysts Recommend for Altria ahead of 4Q17 Earnings
    Market Realist23 days ago

    What Analysts Recommend for Altria ahead of 4Q17 Earnings

    Can Altria Outperform Analyst Estimates in 4Q17?

  • Altria’s 4Q17 Earnings: Why Investors Are Optimistic
    Market Realist24 days ago

    Altria’s 4Q17 Earnings: Why Investors Are Optimistic

    Can Altria Outperform Analyst Estimates in 4Q17?Stock performance

  • How Philip Morris Stock Reacted to Jefferies’ Upgrade
    Market Realist26 days ago

    How Philip Morris Stock Reacted to Jefferies’ Upgrade

    Why Jefferies Upgraded Philip Morris International

  • Why Jefferies Upgraded Philip Morris International
    Market Realist26 days ago

    Why Jefferies Upgraded Philip Morris International

    On January 19, 2018, Jefferies upgraded Philip Morris International (PM) from “hold” to “buy” and raised its 12-month target price to $124. The new target price represents a return potential of 13.8% from its current stock price of $108.92. Owen Bennett of Jeffries expects the Tobacco Products Scientific Advisory Committee’s review of Philip Morris’s iQOS system, which is expected to be announced this week, to drive Philip Morris’s stock price.

  • Altria Stock Rises after Upgrade
    Market Realist27 days ago

    Altria Stock Rises after Upgrade

    Why Jefferies Upgraded Altria Group

  • Why Jefferies Upgraded Altria Group
    Market Realist27 days ago

    Why Jefferies Upgraded Altria Group

    On January 19, 2018, Jefferies upgraded Altria Group (MO) from “hold” to “buy,” and raised its target price from $72 to $81. The new price target represents a return potential of 13.9% based on its current stock price of $71.12. Jefferies analyst Owen Bennett is optimistic on tobacco companies, based on them having a lower valuation than other staples.

  • Benzingalast month

    On This Day In Market History: Surgeon General First Warns Of Smoking Hazard

    Each day, Benzinga takes a look back at a notable market-related moment that happened on this date. What Happened On this day in 1964, the U.S. government issued its first health warning against cigarettes. ...

  • MarketWatchlast month

    FTSE 100 ends at fresh record as Wm. Morrison leads grocers

    U.K. stocks finish higher Tuesday, with the blue-chip index nabbing another record as Wm. Morrison Supermarkets PLC helps lead gains in retail shares following its upbeat Christmas sales update.

  • Reuterslast month

    BAT sees lift from U.S. tax change, plans to reinvest it

    British American Tobacco (BATS.L) said new U.S tax rules would boost its earnings per share by 6 percent in 2018, supporting its commitment to high-single-digit earnings growth and greater investment in vaping devices. Jefferies analysts estimated the 6 percent benefit equates to around 400 million pounds ($541 million), or about 2 percent of sales, and suggested the investment could help BAT compete against Philip Morris International (PM.N) in the growing market for cigarette alternatives seen as less dangerous than smoking. "A key factor weighing on the multiple relative to Philip Morris has been a feeling that they are trailing in reduced risk," the analysts said, noting that 2018 will be a "huge year" in shaping the competitive environment for so-called reduced risk products.

  • Reuterslast month

    BAT sees 6 pct earnings-per-share boost from U.S. tax change

    British American Tobacco said on Tuesday that new U.S tax rules would boost its earnings per share by 6 percent in 2018, all other things being equal, supporting its commitment to high-single digit earnings ...

  • 3 Tobacco Stocks to Buy for 2018
    Motley Fool2 months ago

    3 Tobacco Stocks to Buy for 2018

    The field is shrinking, but there are still clearly some winners.